Amid outrage and tumbling stocks, Mylan’s chairman pocketed $97M | Ars Technica - discu.eu

Linking pages

Pfizer CEO gets 61% pay raise—to $27.9 million—as drug prices continue to climb – Ars Technica https://arstechnica.com/science/2018/03/amid-drug-price-increases-pfizer-ceo-gets-61-pay-raise-to-27-9-million/?amp=1 1195 comments
Pfizer CEO gets 61% pay raise—to $27.9 million—as drug prices continue to climb | Ars Technica https://arstechnica.com/science/2018/03/amid-drug-price-increases-pfizer-ceo-gets-61-pay-raise-to-27-9-million/ 141 comments
Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica https://arstechnica.com/science/2017/06/mylan-chairman-drug-pricing-critics-ought-to-go-copulate-with-themselves/ 7 comments
With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016 | Ars Technica https://arstechnica.com/science/2017/06/with-help-of-coal-tax-credits-mylan-had-a-negative-294-percent-tax-rate-in-2016/ 3 comments
Imagining Elon Musk’s Million-Person Mars Colony – Chapters 1 to 6 | MarshallBrain.com https://marshallbrain.com/mars 1 comment

Linked pages

Related searches:

Search whole site: site:arstechnica.com

Search title: Amid outrage and tumbling stocks, Mylan’s chairman pocketed $97M | Ars Technica

See how to search.

Submit link to: